TELESTA THERAPEUTICS INC T.TST

Answers from Jennifer

[rhdmd]

Hello Dr. XXXXX,

Here are our responses to your questions:

1. This means that Bioniche Therapeutics Corp. is a separate, private corporation that is currently 100% owned by Bioniche Life Sciences Inc.

2. BLSI owns the Therapeutics subsidiary, so BLSI shareholders retain a vested interest.

3. There is no relinquishing of assets. The MCC IP is owned by BLSI and the use of this IP for bladder cancer is licensed down to the Therapeutics subsidiary (no different than the arrangement with Endo).

4. A public company can own a private entity. Any value accrued in the private subsidiary will accrue to BLSI as owner of the sub and, therefore, will accrue to BLSI shareholders.

5. The assets will be valued at such time as licensing deals are completed. We are actively in discussions with potential licensing partners.

Sincerely,

Jennifer


Jennifer Shea
Vice-President, Communications, Investor & Government Relations
Bioniche Life Sciences Inc.
P.O. Box 1570
Belleville, Ontario
K8N 5J2
Phone: [phone]
Fax: [phone]
Cell: 613-391-2097
Email: [e-mail]